RenovoRx (RNXT) Current Assets (2020 - 2026)

RenovoRx has disclosed Current Assets across 7 years of filings, most recently posting $10.8 million for Q2 2026.

• In Q2 2026, Current Assets fell 19.3% year-over-year to $10.8 million; the TTM figure through Jun 2026 stood at $10.8 million (down 19.3% YoY), while the FY2025 annual figure was $7.9 million, up 0.83% from the prior year.
• Current Assets came in at $10.8 million for Q2 2026 at RenovoRx, down from $13.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $15.7 million in Q1 2025 to a low of $1.5 million in Q4 2023.
• Average Current Assets over 5 years is $10.3 million, with a median of $10.9 million recorded in 2025.
• Year-over-year, Current Assets plunged 79.82% in 2023 and surged 433.97% in 2024.
• Over 5 years, Current Assets stood at $7.3 million in 2022, then sank by 79.82% to $1.5 million in 2023, then surged by 433.97% to $7.8 million in 2024, then increased by 0.83% to $7.9 million in 2025, then soared by 36.96% to $10.8 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $10.8 million in Q2 2026, $13.7 million in Q1 2026, and $7.9 million in Q4 2025.